Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Multivariate Cox regression analysis for ECG-4 and ECG-5

From: Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease

  ECG-4 ECG-5
Variables HR (95% CI) p HR (95% CI) p
Age at each visit 1.05 (1.01–1.07) 0.002 1.04 (1.007–1.06) 0.01
AMS (2 years prior to ECG) 1.08 (1.02–1.16) 0.009 1.07 (1.002–1.14) 0.04
SDI 1.29 (1.10–1.53) 0.002 1.28 (1.08–1.51) 0.004
Hyperlipidemia on statins ever before ECG 0.44 (0.21–0.89) 0.02 0.44 (0.22–0.87) 0.02
Hypertension 0.66 (0.34–1.26) 0.21 0.75 (0.4–1.39) 0.36
Ever smoked before ECG 1.13 (0.59–2.16) 0.71 1.09 (0.58–2.06) 0.77
Immunosuppressive treatment at each visit 1.88 (1.01–3.51) 0.05 1.67 (0.93–3.04) 0.09
Antimalarial treatment at each visit 1.76 (0.87–3.58) 0.12 1.81 (0.92–3.56) 0.12
  1. Akaike information criterion (AIC) = 334.6
  2. AMS adjusted mean SLEDAI-2 K, CI confidence interval, ECG electrocardiogram, HR hazard ratio, SDI SLICC/American College of Rheumatology Damage Index, SLE systemic lupus erythematosus, SLEDAI-2 K SLE Disease Activity Index 2000